Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
EQT Nears Deal to Acquire Majority Stake in AMCS
EQT AB agreed to acquire a majority stake in AMCS, a software provider focused on waste management and recycling. EQT Private Equity will invest from EQT X, its flagship private equity fund, and EQT Future, according to a Wednesday statement that confirmed an earlier...
Advent, Bain & Clessidra to buy Italy’s ICBPI for Є2.15bn
Private equity funds Advent International, Bain Capital and Clessidra have signed a binding deal to buy Italian banking services provider ICBPI for 2.15 billion euros ($2.4 billion), the consortium said in a joint statement on Friday. Current ICBPI shareholders will...
India’s SBI aims to sell its Yes Bank stake worth $2.2bn by end-March
State Bank of India (SBI), the country's largest lender, aims to strike a deal by end-March for the sale of its 24% stake worth 184.2 billion rupees ($2.2 billion) currently in smaller rival Yes Bank (YESB.NS) four sources with direct knowledge said. Japanese lender...